What the Research Does NOT Yet Support - There are currently no published randomised controlled trials (RCTs) in humans for BPC-157 - Human pharmacokinetic data (how it is absorbed, distributed, metabolised, and excreted) is limited - Optimal dosing, route of administration, and treatment duration have not been established clinically - Long-term safety data in humans is absent - Regulatory approval from the TGA, FDA, or EMA has not been granted for any therapeutic indication TB-500: Evidence Overview What the Research Supports TB-500 / Thymosin Beta-4 has somewhat more human-facing research, though still predominantly preclinical: Phase I and II clinical trials have investigated Thymosin Beta-4 (the native peptide) in cardiac repair following myocardial infarction, with promising safety profiles Wound healing applications have been explored in clinical settings, particularly for chronic non-healing wounds and dry eye disease Robust animal evidence supports its role in reducing inflammation, supporting angiogenesis, and promoting tissue regeneration The native peptide (T4) has demonstrated cardioprotective effects in animal models of heart failure and ischaemia What the Research Does NOT Yet Support TB-500 is a synthetic fragment of T4 it is not identical to the native peptide, and extrapolating human clinical data from T4 studies directly to TB-500 may not be valid No approved therapeutic indications exist for TB-500 specifically Comparative efficacy versus established treatments has not been studied The long-term effects of exogenous peptide administration on endogenous thymosin beta-4 regulation are unknown Potential Benefits: A Summary Based on the available (predominantly preclinical) literature, the following potential benefits have been identified: Risks & Safety Considerations Known & Reported Side Effects Because large-scale human trials are lacking, our understanding of the side effect profile is limited
Choose MORNING Injection If: Your primary goal is increased daytime energy and mental performance You have a structured morning routine and irregular evenings Youre focused on workout performance and muscle gains You prefer to feel the hormone benefits during your waking day You struggle with consistency in evening routines You want faster initial noticeable results (energy/clarity) Choose NIGHT Injection If: Your primary goal is body composition (fat loss + muscle definition) You prioritize recovery, repair, and sleep quality You have a consistent bedtime routine You want to minimize appetite stimulation during your day Youre willing to monitor for initial sleep adjustment (typically 2-3 weeks) You want maximum alignment with your natural GH rhythm The Testing Approach (Recommended): If youre uncertain, start with one timing for 6-8 weeks and track your results: energy levels, workout performance, sleep quality, appetite, and body composition changes
Patients with migraine-associated CVS have a better response to abortive treatment with triptans and to prophylaxis with propranolol
Too much magnesium can mess with blood thinners
How to avoid it: If you administer both, you must have four groups: Control, 1MQ only, MOTS-C only, and Combination
3: The Derma Co 3% Glutathione Cleanser (9.3/10) Science-Backed Powerhouse text Highest concentration: 3% **glutathione** (preserved via liposomal tech) Includes 2% niacinamide for pore-tightening bonus Oily/acne-prone skins dream no breakouts, just glass skin 649/100ml My Experience : Cleared my T-zone oil while fading acne scars 65% in 8 weeks
